Adipose tissue development is a highly organized process, that involves either hypertrophy (enlargement of existing adipocytes) or hyperplasia (increase in the number of mature adipocytes) or a combination of both [1] . White adipose tissue (WAT) is a major endocrine and secretory organ, releasing fatty acids, different lipid moieties and a multiplicity of adipokines [2] .
the effect of age on adipose tissue development in this model. The objective of this study was to characterize age-associated changes in adipose tissue in naturally ageing male C57BL/6J mice. Since visceral and subcutaneous fat depots are two distinct depots characterized by different patterns of gene expression and regulation [4] , gonadal and subcutaneous inguinal fat were analyzed in 10 weeks, 12 and 24 months old mice.
Materials and Methods

Animal model
Male C57BL/6J mice at the age of 10 weeks, 12 and 24 months were purchased from Janvier (Le Genest Saint Isle, France). All animals were kept in microisolation cages in a temperature and light-controlled (12-h night/day cycle) environment and exposed to drinking water and standard chow (KM-04-k12, Muracon; Carfil, Oud-Turnhout, Belgium) ad libitum. Animals were scanned by non-invasive magnetic resonance imaging (MRI) to determine body volume, total fat volume, subcutaneous (SC) and ab-ture (RT), paraffin-embedded; 10-µm sections were processed onto Superfrost plus slides (Menzel-Glaser, Braunschweig, Germany). The mean adipocyte size was determined by computer-assisted image analysis (KS300, Zeiss, Jena, Germany) of SC and GON fat sections stained with hematoxylin and eosin. The adipocyte density was calculated by dividing the number of adipocytes by the total area of the analyzed section (ten areas divided over four sections were analyzed per animal and the data were subsequently averaged). The vasculature of the SC and GON fat was visualized using biotinylated Bandeiraea (Griffonia) simplicifolia BSI lectin (Sigma-Aldrich, Bornem, Belgium), with signal amplification with the Tyramide Signal Amplification Cyanine system (Perkin Elmer, Boston, MA). The average blood vessel size was calculated by dividing the total stained area by the number of vessels and blood vessel density is expressed as the number of vessels per measured surface area (9-12 sections were analyzed per animal and results were then averaged).
Plasma insulin (Mercodia, Uppsala, Sweden) and leptin (R&D Systems, Lile, France) concentrations were determined using commercially available ELISAs. Plasminogen activator inhibitor-1 (PAI-1) antigen was measured with a specific home-made ELISA [5] . Free fatty acids (FFA) were determined with a commercially available enzymatic colorimetric assay (Roche Diagnostics, Vilvoorde, Belgium). Blood glucose levels were measured using Glucocard strips (Menarini Diagnostics, Florence, Italy) and triglyceride, total cholesterol, HDL-cholesterol levels were evaluated using routine clinical assays. The LDL-cholesterol levels were then calculated according to the following formule: LDL-cholesterol = total cholesterol -HDL-cholesterol -(triglycerides/5).
Statistical analysis
GraphPad Prism 4.03 software was used to determine statistical differences and statistical significant correlations (GraphPad, La Jolla, CA). Data are represented as means ± SEM. Differences between the three age groups were analyzed using the nonparametric Kruskal-Wallis statistical test. If a statistical difference was detected (p < 0.05), the difference between the individual groups was determined using the Dunn´s Multiple Comparison test. Correlation analysis between plasma leptin levels and adiposity measurements was performed using the non-parametric Spearman rank correlation statistical test. dominal (ABD) fat volume. Animals were allowed to recover for approximately one week. At the end of the week after a 4h fast, mice were killed by intraperitoneal injection of 60 mg/kg sodium pentobarbital (Nembutal, Abbott Laboratories, North Chicago, IL) and blood was retrieved from the retro-orbital sinus on trisodium citrate (final concentration 0.01 mol/L) and plasma was stored at -80° C until analysis. The intraabdominal fat surrounding the testes and epididymis (gonadal, GON) and inguinal subcutaneous (SC) fat pads were surgically dissected, weighed and used to prepare 10-µm paraffin sections for histological analysis. All animal procedures were conducted according to the guidelines of the Ethical Committee of the Catholic University of Leuven.
MRI acquisition
Mice were anesthetized using isofluorane (2.5% for induction and 1.5% for maintenance during scanning) in O 2 and positioned on an animal bed. Temperature and respiration were monitored and maintained at 37°C and > 60 min -1 , respectively. Fat-suppressed and non-suppressed images were acquired using a Bruker Biospin 9.4 Biospec Tesla small animal scanner (Bruker Biospin, Ettlingen, Germany) equipped with an actively shielded gradient set of 600 mT/m using a respiration triggered spin echo sequence (RARE) with 55 continuous slices of 0.6 mm thickness in interlaced mode (other parameters were: TR = 6000 ms, TE = 15.9 ms, FOV = 5.0 × 10.0 cm, a matrix of 256 × 400, two dummy scans and two averages). The fatsuppressed scan was repeated with the same receiver gain setting as for the non-suppressed dataset (fat suppression bandwidth = 1400 Hz). Both datasets were imported into in-house developed software for further processing (see below). For RF irradiation and detection a 7.2 cm quadrature resonator (Bruker Biospin, Ettlingen) was used. The segmentation algorithm will automatically segment the body and fatty tissue, allowing calculation of the fat percentage per body volume. Another algorithm segments the ABD and SC fat depots by delineation of the visceral cavity, allowing automatic calculation of the SC and ABD fat volumes.
Assays
Fat tissues were fixated overnight in Shandon Zinc Formal-Fixx (Anatomical Pathology International, Chester, UK) for 20 h, washed 3 times (10 min each) in PBS, transferred to 70% ethanol at room tempera-
Results
Total body weight of C57BL/6J mice kept on normal chow increased significantly between the age of 10 weeks and 12 months, and slightly decreased again up to 24 months of age (Fig. 1) . Non-invasive, in vivo MRI revealed a higher total body fat content and higher volume of both SC and ABD fat depots, at 12 months as compared to 10 weeks, which markedly declined up to 24 months of age. This temporal pattern of adiposity was confirmed by isolating the SC and GON adipose tissues; the weight of both fat depots increased significantly between 10 weeks and 12 months, and decreased sharply up to 24 months ( Fig.  2A) . Adipocyte size in SC and GON adipose tissues slightly increased between 10 weeks and 12 months, but was significantly lower at 24 months as compared to 12 months, confirming adipocyte hypotrophy (Fig.  2B) . In our analysis, adipocyte size and density are negatively correlated with each other. In concordance with the change in adipocyte size, adipocyte density was not markedly different between 10 weeks and 12 months (954 ± 67 vs. 847 ± 46 x10 -6 /µm 2 for SC and 578 ± 17 vs. 428 ± 35 x10 -6 /µm 2 for GON fat) but was significantly higher at 24 months (1580 ± 134 x10 -6 / µm 2 for SC and 911 ± 108 x10 -6 /µm 2 for GON fat; both p < 0.05 vs. 12 months of age).
Blood vessel size in SC adipose tissue was higher at 12 months as compared to either 10 weeks or 24 months, whereas for GON adipose tissue no significant differences were observed between the three age groups (Fig. 2C ). Blood vessel density in SC fat was enhanced at 24 months (1156 ± 64 vs. 697 ± 34 x10 -6 / µm 2 at 12 months, p < 0.05, and vs. 872 ± 68 x10 -6 / µm 2 at 10 weeks), whereas for GON fat no significant differences were observed between 10 weeks (440 ± 32 x10 -6 /µm 2 ), 12 months (350 ± 30 x10 -6 /µm 2 ) and 24 months (464 ± 61 x10 -6 /µm 2 ). Analysis of plasma metabolic parameters (Table  1 ) revealed a decrease in glucose levels at 24 months compared to 12 months and of insulin levels already at 12 months versus 10 weeks of age. Total cholesterol and HDL-cholesterol levels slightly increased with age, whereas LDL-cholesterol levels were elevated at 24 months. FFA and triglyceride levels did not significantly change with age. Plasma PAI-1 levels remained similar between the age of 10 weeks and 12 months (3.24 ± 0.27 ng/mL vs. 2.92 ± 0.25 ng/mL, p > 0.05), and subsequently slightly increased between the age of 12 and 24 months (2.92 ± 0.25 ng/mL vs. 4.11 ± 0.44 ng/mL, p > 0.05). Plasma leptin levels showed a biphasic pattern with age as they were significantly elevated at 12 months as compared to 10 weeks, but markedly reduced again at 24 months. Plasma leptin levels correlated positively with body weight (r = 0.53; p = 0.04), with SC fat mass (r = 0.85; p < 0.0001) and with GON fat mass (r = 0.73; p = 0.002).
discussion
In humans, a pattern of progressive loss of SC and gain of visceral fat throughout life has been demonstrated [6] . Increased intake of energy-rich foods, a decrease in lean body mass (resulting in a reduction of fat oxidation in particular by skeletal muscle) and physical inactivity are some of the many factors contributing to the increased fat accumulation in the elderly population. Another factor includes adipocyte changes in lipolytic activity or FFA synthesis and uptake with age [7] . All these complications progressively induce the development of insulin resistance, fat accretion and obesity-associated diseases in older people. Mice with a C57Bl/6 genetic background and a wide age range have been used as a preferred model to study obesity and metabolic diseases. However, little information is available on the effect of age on adipose tissue development in this model. In this study, we have observed a biphasic pattern (increase between 10 weeks and 12 months of age -decrease between 12 and 24 months) of body weight, SC and GON fat mass, adipocyte and blood vessel size. Data obtained by automated analysis of in vivo MRI scans correlated well with data obtained on isolated fat depots.
The increase in body weight between the age of 10 plasma insulin levels and glucose levels decrease, which will result in a much lower HOMA-index, suggesting that 24 months old mice have the best insulin sensitivity. It is known that centenarians also have a much lower plasma glucose and insulin level and a better insulin sensitivity than young individuals [10, 11] . Plasma levels of other adipokines such as monocyte chemoattractant protein-1 (MCP-1) and PAI-1 have been shown to be elevated in obese mice and both are able to decrease insulin-stimulated glucose uptake in adipocytes, indicating the involvement of these proteins in insulin resistance [12] . The plasma levels of MCP-1 were not analyzed, however PAI-1 plasma levels were determined. Plasma PAI-1 antigen levels remained similar between 10 weeks and 12 months and subsequently slightly increased up to the age of 24 months. These data suggest PAI-1 is not involved in the amelioration of age-related insulin sensitivity in C57BL/6J mice. The lipid profile of the blood has not been shifted drastically with age, except for increased LDL-cholesterol levels. Triglyceride and FFA levels remain unchanged. In this study, we detected age-associated changes in fat mass and composition in C57Bl/6 mice that are relevant for the design of obesity or metabolic studies in this model and may act as a baseline for such future studies.
weeks and 12 months is associated with fat accumulation in subcutaneous and abdominal regions of the body. The increase in mass of the SC fat depot seems to be linked to an increase in blood vessel size and not to an increase in adipocyte size. The increase in visceral (gonadal) fat mass seems associated with a slight increase in adipocyte size without effect on blood vessel size. It is conceivable that due to a different expression of pro-and anti-angiogenic factors in SC and GON fat at a different age, the role of blood vessel formation on adipose tissue growth is different. A similar finding has been reported by Cousin [4] . Plasma leptin levels are enhanced proportionally with increased body weight, SC and GON fat weight. Plasma insulin levels are decreased in 12 months versus 10 weeks old mice, while plasma glucose levels remain the same. Thus, the HOMA-index will be lower in the 12-months old mice, suggesting better insulin sensitivity.
Between the age of 12 and 24 months body weight only slightly decreases, whereas the SC and GON fat mass decreases significantly. The reduction in SC fat is associated with a decrease in both adipocyte and blood vessel size, whereas in GON fat only a reduction of adipocyte size was observed. At the age of 24 months, muscle volume changes might also occur and influence body weight and plasma adipokine levels. This was illustrated by a study by Hamrick et al. [8] . They found a statistical significant decline in hind limb muscle mass and bone tissue in male C57BL/6J mice between the ages of 18 and 24 months and in addition, these changes were associated with a decrease in serum leptin levels. In murine models of premature ageing such as the brain and muscle ARNT-like protein-1 (Bmal1) deficient mice, muscle mass also decreases with age [9] . In concordance with the study of Hamrick et al., a drop in plasma leptin levels was noticed between the ages of 12 and 24 months, that may be explained by a reduction in fat mass and muscle mass. More advanced age is also associated with a decrease in plasma glucose levels, while plasma insulin levels remain similar to the 12 months level. At the age of 24 months compared to the age of 10 weeks
